We initially selected three genes (PAK1, RAF1, and GRB2) based on their involvement in critical molecular signaling networks, including the MAPK signaling pathway, proteoglycans in cancer, focal adhesion, and natural killer cell-mediated cytotoxicity. Here, GRB2 is linked to cancer.